Next Science Limited (NXS.AX)
AUD 0.1
(-1.0%)
AUD 0.1
(-1.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -23.4 Million USD | -31.85% |
| 2022 | -18.31 Million USD | -43.07% |
| 2021 | -12.8 Million AUD | 29.68% |
| 2020 | -18.2 Million AUD | -0.92% |
| 2019 | -18.03 Million AUD | 2.91% |
| 2018 | -18.57 Million AUD | -37713.29% |
| 2017 | -49.13 Thousand AUD | 98.87% |
| 2016 | -4.33 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -8.78 Million AUD | 27.59% |
| 2023 FY | -24.14 Million USD | -31.85% |
| 2023 Q2 | -12.24 Million AUD | -34.68% |
| 2023 Q4 | -11.88 Million AUD | 2.88% |
| 2022 Q2 | -9.19 Million AUD | -26.26% |
| 2022 FY | -18.31 Million USD | -43.07% |
| 2022 Q4 | -9.08 Million AUD | 1.13% |
| 2021 FY | -12.8 Million AUD | 29.68% |
| 2021 Q2 | -5.55 Million AUD | 28.55% |
| 2021 Q4 | -7.28 Million AUD | -31.18% |
| 2020 FY | -18.2 Million AUD | -0.92% |
| 2020 Q2 | -10.53 Million AUD | -19.99% |
| 2020 Q4 | -7.76 Million AUD | 26.26% |
| 2019 Q4 | -8.78 Million AUD | 4.97% |
| 2019 FY | -18.03 Million AUD | 2.91% |
| 2019 Q2 | -9.23 Million AUD | -111.37% |
| 2018 FY | -18.57 Million AUD | -37713.29% |
| 2018 Q4 | -4.37 Million AUD | 0.0% |
| 2017 FY | -49.13 Thousand AUD | 98.87% |
| 2016 FY | -4.33 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Althea Group Holdings Limited | -11.69 Million AUD | -100.101% |
| Cann Group Limited | -13.47 Million AUD | -73.661% |
| ECS Botanics Holdings Ltd | 1.43 Million AUD | 1727.069% |
| Ecofibre Limited | -15.02 Million AUD | -55.772% |
| Elixinol Wellness Limited | -5.99 Million AUD | -290.782% |
| Hygrovest Limited | -1.1 Million AUD | -2022.197% |
| IDT Australia Limited | -4.94 Million AUD | -372.981% |
| Invion Limited | -7.55 Million AUD | -209.947% |
| Little Green Pharma Ltd | -7.62 Million AUD | -206.875% |
| Live Verdure Ltd | -12.54 Million AUD | -86.663% |
| Medical Developments International Limited | -16.86 Million AUD | -38.779% |
| Vitura Health Limited | 4.86 Million AUD | 580.937% |
| Vita Life Sciences Limited | 12.21 Million AUD | 291.632% |